|
May 13
|
Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine
|
|
May 13
|
While shareholders of Moderna (NASDAQ:MRNA) are in the black over 5 years, those who bought a week ago aren't so fortunate
|
|
May 13
|
Company News For May 13, 2024
|
|
May 13
|
Investors Heavily Search Moderna, Inc. (MRNA): Here is What You Need to Know
|
|
May 13
|
Bull Market and Beyond: 2 Stocks Just Waiting to Soar
|
|
May 13
|
Moderna to Present at Upcoming Conferences in May/June 2024
|
|
May 12
|
Moderna and OpenAI Are Teaming Up, but Does That Make the Stock a Buy?
|
|
May 10
|
Novavax stock doubles after Sanofi deal marks 'new chapter' for company
|
|
May 10
|
Moderna Tumbles After The FDA Throws A Curveball On Its Second Product
|
|
May 10
|
Consumer sentiment drops, Tesla's Supercharger, Zeekr IPO: Catalysts
|
|
May 10
|
Top Midday Stories: Biden to Reportedly Quadruple Chinese EV Tariffs; Novavax Shares Soar on Sanofi Deal News; Protesters Try to Break Into Tesla's Plant in Germany; FDA Pushes Back Approval of Moderna Vaccine
|
|
May 10
|
Moderna: FDA postpones RSV vaccine approval
|
|
May 10
|
Moderna's RSV Vaccine Review Delayed by FDA to End of May
|
|
May 10
|
FDA Delays Decision on Moderna RSV Shot by 3 Weeks
|
|
May 10
|
FDA delays decision on Moderna RSV vaccine
|
|
May 10
|
US FDA pushes decision on Moderna's RSV vaccine to end of this month
|
|
May 10
|
Moderna Announces Update on Investigational RSV Vaccine
|
|
May 9
|
Moderna's Promise of mRNA Undercut by New RSV Vaccine
|
|
May 9
|
Sisk selected for MITC fit-out in Oxfordshire
|
|
May 9
|
If You'd Invested $1,000 in Moderna Stock 5 Years Ago, Here's How Much You'd Have Today
|